InvestorsHub Logo
Followers 4
Posts 269
Boards Moderated 0
Alias Born 03/28/2018

Re: the big guy post# 7103

Thursday, 12/27/2018 9:42:00 PM

Thursday, December 27, 2018 9:42:00 PM

Post# of 7900
Yep. Stay away from “analysts” opinions on RASD’s. Most OR staff don’t even understand the complexities of this type of surgical procedure.

Transenterix has one single product, “Senhance” and it is a RASD (Robotic Assisted Surgical Device) that was built by SOFAR in 2009. SOFAR, a Italian pharmaceutical company built this device and named it Telap ALF-X, they are based in Milan, Italy and partnered with a few clinical hospitals in Rome for testing and clinical studies. In 2013, ALF-X received CE clearance in Europe for these trials. From 2013 to 2016 clinical studies were conducted and proved Alf-x was not a viable platform based on Laparoscopic comparison. The clinical data is available at Transenterix own website that redirects to NCBI




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ASXC News